Hence, expression of the EGF‐inducible lncRNAs we uncovered was examined in large cohorts of breast cancer patients, with the vision of identifying potential drivers and biomarkers of the basal‐like and the HER2‐enriched subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.